Kidney injury biomarkers and urinary creatinine variability in nominally healthy adults

References

• Ahmed ARH, Griffiths AB, Tilby MT, et al. (2012). TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease. Am J Pathol 180:904–16.
   PubMed Web of Science ®Google Scholar
• Andersen EM, Sobus JR, Strynar MJ, et al. (2014). Evaluating an alternative method for rapid urinary creatinine determination. J Toxicol Environ Health Part A 77:1114–23.
   PubMed Web of Science ®Google Scholar
• Angerer J, Ewers U, Wilhelm M. (2007). Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201–28.
   PubMed Web of Science ®Google Scholar
• Angrish MM, Madden MC, Pleil JD. (2015). Probe molecule (PrM) approach in adverse outcome pathway (AOP) based high-throughput screening (HTS): in vivo discovery for developing in vitro target methods. Chem Res Toxicol 28:551–9.
   PubMed Web of Science ®Google Scholar
• Ankley GT, Bennett RS, Erickson RJ, et al. (2010). Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–41.
   PubMed Web of Science ®Google Scholar
• Au WW. (2007). Usefulness of biomarkers in population studies: from exposure to susceptibility and to prediction of cancer. Int J Hyg Environ Health 210:239–46.
   PubMed Web of Science ®Google Scholar
• Barr DB, Wilder LC, Caudill SP, et al. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192–200.
   PubMed Web of Science ®Google Scholar
• Bean HD, Pleil JD, Hill JE. (2015). Editorial: new analytical and statistical approaches for interpreting the relationships among environmental stressors and biomarkers. Biomarkers 20:1–4.
   PubMed Web of Science ®Google Scholar
• Becker J, Friedman E. (2013). Renal function status. Am J Roentgenol 200:827–9.
   PubMed Web of Science ®Google Scholar
• Boeniger MF, Lowry LK, Rosenberg J. (1993). Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615–27.
   PubMed Web of Science ®Google Scholar
• Bolt MJG, Cao LP, Kong J, et al. (2005). Vitamin D receptor is required for dietary calcium-induced repression of calbindin-D9k expression in mice. J Nutr Biochem 16:286–90.
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Vaidya VS, Schmouder R, et al. (2010). Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 28:436–40.
   PubMed Web of Science ®Google Scholar
• Branten AJ, Mulder TB, Peters WH, et al. (2000). Urinary excretion of glutathione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 85:120–6.
   PubMed Web of Science ®Google Scholar
• Chadeau-Hyam M, Campanella G, Jombart T, et al. (2013). Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers. Environ Mol Mutagen 54:542–57.
   PubMed Web of Science ®Google Scholar
• Choudhury D, Ahmed Z. (2006). Drug associated renal dysfunction and injury. Nat Clin Pract Nephrol 2:80–91.
   PubMedGoogle Scholar
• Cohen Hubal EA, Richard A, Aylward L, et al. (2010). Advancing exposure characterization for chemical evaluation and risk assessment. J Toxicol Environ Health B Crit Rev 13:299–313.
   PubMed Web of Science ®Google Scholar
• Doi K, Noiri E, Fujita T. (2010). Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol 8:122–8.
   PubMed Web of Science ®Google Scholar
• Edwards SW, Preston RJ. (2008). Systems biology and mode of action based risk assessment. Toxicol Sci 106:312–8.
   PubMed Web of Science ®Google Scholar
• Fuchs TC, Hewitt P. (2011). Biomarkers for drug-induced renal damage and nephrotoxicity – an overview for applied toxicology. AAPS J 13:615–31.
   PubMed Web of Science ®Google Scholar
• Giffen PS, Pick CR, Price MA, et al. (2002). Alpha-glutathione S-transferase in the assessment of hepatotoxicity-its diagnostic utility in comparison with other recognized markers in the Wistar Han rat. Toxicol Pathol 30:365–72.
   PubMed Web of Science ®Google Scholar
• Halloy S, Whigham P. (2005). The lognormal as universal descriptor of unconstrained complex systems: a unifying theory for complexity. Complexity Int 12:1–12.
   Google Scholar
• Harrell FE. (2015). Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. New York: Springer International Publishing, 63–102.
   Google Scholar
• Henderson AR. (2006). Testing experimental data for univariate normality. Clin Chim Acta 366:112–29.
   PubMed Web of Science ®Google Scholar
• Hill RH, Head SL, Baker S, et al. (1995). Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res 71:99–108.
   PubMed Web of Science ®Google Scholar
• Hoeben A, Landuyt B, Highley MS, et al. (2004). Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549–80.
   PubMed Web of Science ®Google Scholar
• Houck KA, Dix DJ, Judson RS, et al. (2009). Profiling bioactivity of the ToxCast chemical library using BioMAP primary human cell systems. J Biomol Screen 14:1054–66.
   PubMed Web of Science ®Google Scholar
• Hudmon KS, Honn SE, Jiang H, et al. (1997). Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev 6:565–71.
   PubMed Web of Science ®Google Scholar
• Jones SE, Jomary C. (2002). Clusterin. Int J Biochem Cell Biol 3r4:427–31.
   Web of Science ®Google Scholar
• Kavlock R, Dix D. (2010). Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk. J Toxicol Environ Health B Crit Rev 13:197–217.
   PubMed Web of Science ®Google Scholar
• Lee HW, Lawton C, Na YJ, et al. (2013). Robustness of chemometrics-based feature selection methods in early cancer detection and biomarker discovery. Stat Appl Genet Mol Biol 122:207–23.
   Google Scholar
• Limpert E, Stahel WA, Abbt M. (2001). Lognormal distributions across the sciences: keys and clues. Biosci 51:341–52.
   Web of Science ®Google Scholar
• Lind PM, Riserus U, Salihovic S, et al. (2013). An environmental wide association study (EWAS) approach to the metabolic syndrome. Environ Int 55:1–8.
   PubMed Web of Science ®Google Scholar
• Lioy PJ. (1990). Exposure analysis and assessment for low-risk cancer agents. Int J Epidemiol 19:S53–61.
   PubMed Web of Science ®Google Scholar
• Lock EA. (2010). Sensitive and early markers of renal injury: where are we and what is the way forward? Toxicol Sci 116:1–4.
   PubMed Web of Science ®Google Scholar
• Lu SS, Sobus JR, Sallsten G, et al. (2014). Are urinary PAHs biomarkers of controlled exposure to diesel exhaust? Biomarkers 19:332–9.
   PubMed Web of Science ®Google Scholar
• Meeker JD, Cooper EM, Stapleton HM, Hauser R. (2013). Urinary metabolites of organophosphate flame retardants: temporal variability and correlations with house dust concentrations. Environ Health Perspect 121:580–5.
   PubMed Web of Science ®Google Scholar
• Muscat JE, Liu A, Richie JP. (2011). A comparison of creatinine vs. specific gravity to correct for urinary dilution of cotinine. Biomarkers 16:206–11.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Ishil A, Ohata C, Kamurasaki T. (2007). Early induction of osteoactivin expression in rat renal tubular epithelial cells after unilateral ureteral obstruction. Exp Toxicol Pathol 59:53–9.
   PubMed Web of Science ®Google Scholar
• Patel CJ, Bhattacharya J, Butte AJ. (2010). An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One 5:e10746
   PubMed Web of Science ®Google Scholar
• Patel-Chamberlin M, Wang Y, Satirapoj B, et al. (2011). Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species. Kidney Int 79:1138–48.
   PubMed Web of Science ®Google Scholar
• Paustenbach D, Galbraith D. (2006). Biomonitoring and biomarkers: exposure assessment will never be the same. Environ Health Perspect 114:1143–9.
   PubMed Web of Science ®Google Scholar
• Phillips M, Altorki N, Austin JHM, et al. (2008). Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta 393:76–84.
   PubMed Web of Science ®Google Scholar
• Pleil JD. (2008). The role of exhaled breath biomarkers in environmental health science. J Toxicol Environ Health B Crit Rev 11:613–26.
   PubMed Web of Science ®Google Scholar
• Pleil JD. (2009). Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers. Biomarkers 14:560–71.
   PubMed Web of Science ®Google Scholar
• Pleil JD. (2012). Categorizing biomarkers of the human exposome and developing metrics for assessing environmental sustainability. J Toxicol Environ Health B Crit Rev 15:264–80.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Blount BC, Waidyanatha S, Harper M. (2012a). Establishing exposure science as a distinct scientific discipline. J Expo Sci Environ Epidemiol 22:317–9.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Kim D, Prah JD, Rappaport SM. (2007). Exposure reconstruction for reducing uncertainty in risk assessment: example using MTBE biomarkers and a simple pharmacokinetic model. Biomarkers 12:331–48.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Miekisch W, Stiegel MA, Beauchamp JD. (2014a). Extending breath analysis to the cellular level: current thoughts on the human microbiome and the expression of organic compounds in the human exposome. J Breath Res 8:029001.
   Web of Science ®Google Scholar
• Pleil JD, Lorber MN. (2007). Relative congener scaling of polychlorinated dibenzo-p-dioxins and dibenzofurans to estimate building fire contributions in air, surface wipes, and dust samples. Environ Sci Technol 41:7286–93
   PubMed Web of Science ®Google Scholar
• Pleil JD, Sheldon LS. (2011). Adapting concepts from systems biology to develop systems exposure event networks for exposure science research. Biomarkers 16:99–105.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Sobus JR. (2013). Estimating lifetime risk from spot biomarker data and intra-class correlation coefficients (ICC). J Toxicol Environ Health A 76:747–66.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Sobus JR, Stiegel MA, et al. (2014b). Estimating common parameters of log-normally distributed environmental and biomonitoring data: harmonizing disparate statistics from publications. J Toxicol Environ Health B Crit Rev 17:341–68.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Stiegel MA, Sobus JR. (2011a). Breath biomarkers in environmental health science: exploring patterns in the human exposome. J Breath Res 5:046005.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Stiegel MA, Madden MC, Sobus JR. (2011b). Heat map visualization of complex environmental and biomarker measurements. Chemosphere 84:716–23.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Stiegel MA, Sobus JR, et al. (2011c). Observing the human exposome as reflected in breath biomarkers: heat map data interpretation for environmental and intelligence research. J Breath Res 5:037104.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Stiegel MA. (2013). Evolution of environmental exposure science: using breath-borne biomarkers for “discovery” of the human exposome. Anal Chem 85:9984–90.
   PubMed Web of Science ®Google Scholar
• Pleil JD, Williams M, Sobus JR. (2012b). Chemical Safety for Sustainability (CSS): human in vivo biomonitoring data for complementing results from in vitro toxicology – a commentary. Toxicol Lett 215:201–7.
   PubMed Web of Science ®Google Scholar
• Rappaport SM. (2012a). Discovering environmental causes of disease. J Epidemiol Community Health 66:99–102.
   PubMed Web of Science ®Google Scholar
• Rappaport SM. (2012b). Biomarkers intersect with the exposome. Biomarkers 17:483–9.
   PubMed Web of Science ®Google Scholar
• Rappaport SM, Smith MT. (2010). Epidemiology: environment and disease risks. Science 330:460–1.
   PubMed Web of Science ®Google Scholar
• Richards FJ. (1959). A flexible growth function for empirical use. J Exp Bot 10:290–300.
   Web of Science ®Google Scholar
• Sheng MHC, Wergedal JE, Mohan S, Lau KHW. (2008). Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett 582:1451–8.
   PubMed Web of Science ®Google Scholar
• Siew ED, Ware LB, Ikizle TA. (2011). Biological markers of acute kidney injury. J Am Soc Nephrol 22:810–20.
   PubMed Web of Science ®Google Scholar
• Sobus JR, DeWoskin RS, Tan YM, et al. (2015). Uses of NHANES biomarker data for chemical risk assessment: trends, challenges, and opportunities. Environ Health Perspect 123:919–27.
   Google Scholar
• Sobus JR, Tan YM, Pleil JD, Sheldon LS. (2011). A biomonitoring framework to support exposure and risk assessments. Sci Total Environ 409:4875–84.
   PubMed Web of Science ®Google Scholar
• Sondag GR, Salihoglu S, Lababidi SL, et al. (2014). Osteoactivin induces transdifferentiation of C2C12 myoblasts into osteoblasts. J Cell Physiol 221:955–66.
   Web of Science ®Google Scholar
• Stiegel MA, Pleil JD, Sobus JR, et al. (2015). Analysis of inflammatory cytokines in human blood, breath condensate, and urine using a multiplex immunoassay platform. Biomarkers 20:35–46.
   PubMed Web of Science ®Google Scholar
• Tan YM, Sobus JR, Chang D, et al. (2012). Reconstructing human exposures using biomarkers of exposure and other clues. J Toxicol Environl Health B Crit Rev 15:22–38.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (USEPA). (2008). Scientific and ethical approaches for observational exposure studies (SEAOS). Washington, DC, USA: Office of Research and Development. EPA/600/R-08/062
   Google Scholar
• Vaidya VS, Ramirez V, Ichimura T, et al. (2006). Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290:F517–29.
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ozer JS, Dieterle F, et al. (2010). Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28:478–85.
   PubMed Web of Science ®Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, et al. (2014a). Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142:312–20.
   PubMed Web of Science ®Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, et al. (2014b). Adverse outcome pathway development II: best practices. Toxicol Sci 142:321–30.
   PubMed Web of Science ®Google Scholar
• Vinken M. (2013). The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158–65.
   PubMed Web of Science ®Google Scholar
• Wambaugh JF, Setzer RW, Reif DM, et al. (2013). High-throughput models for exposure-based chemical prioritization in the ExpoCast project. Environ Sci Technol 47:8479–88.
   PubMed Web of Science ®Google Scholar
• Yu Y, Jin H, Holder D, et al. (2010). Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotechnol 28:470–7
   PubMed Web of Science ®Google Scholar